CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 367 enrolled
Drug / intervention
Non-interventional cross-sectional surveyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02020967
NCT02020967N/ACompleted
CompareCT.gov

Programme of Acromegaly Screening in Patients With Associated Somatic Disorders, Who Are Observed at the Moscow Board of Health Endocrinology Dispensary and Endocrinology Hospital at First Moscow State Medical University for the Purpose of Early Identification of the Disease.

Ipsen·observational·Posted Dec 25, 2013·Updated May 26, 2021

In Brief

An observational study evaluating Non-interventional cross-sectional survey for Acromegaly. Completed, enrolled 367 participants across 2 sites.

Detailed Summary

The primary objective of the protocol is to define percentage of patients with acromegaly in relation to the total number of screened patients with confirmed clinically significant set of associated somatic disorders with the help of laboratory (Insulin-like Growth Factor I, Growth Hormone, Oral Glucose-Tolerance Test \[IGF-1, GH, OGTT\]) and instrumental examination methods (Magnetic Resonance Imaging \[MRI\]).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcromegaly
CountriesRussia
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 25, 2013
Enrollment StartDec 5, 2013
Primary CompletionSep 15, 2015
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 12.5 years ago

Interventions

Non-interventional cross-sectional surveyother

This is a survey which does not involve any intervention into routine clinical practice, including the use of any investigational therapy or special examination methods.